NXN Nexsen Limited
—Mkt Cap: —P/E: —1d ago
Nexsen Limited operates as a nanobiotechnology company that develops proprietary biosensing platforms for rapid, high-precision point-of-care (POC) medical diagnostics and point-of-use sensing for human health, food and …
Industry Peers
Biotechnology$128.87BUSDP/E 29.6
$94.42BUSD
$81.99BUSDP/E 19.1
$53.47BUSDP/E 32.5
$53.22BUSDP/E 31.6
$44.02BUSDP/E 17.8
$42.56BUSDP/E 66.4
$40.57BUSD
$34.45BUSDP/E 30.4
$31.32BUSDP/E 39.3
$24.59BUSD
$23.32BUSDP/E 31.7
$23.26BUSDP/E 29.8
$22.96BUSDP/E 14.0
$22.66BUSD
$21.67BUSD
$15.57BUSDP/E 19.3
$14.91BUSDP/E 17.4
$13.92BUSDP/E 14.7
$13.79BUSDP/E 33.4
Key Statistics
Company
Market Cap—
Enterprise Value14.89M USD
Revenue (TTM)—
Gross Profit-2.19M USD
Net Income (TTM)-4.53M USD
Revenue/Share—
Last Price—
Fiscal Year EndJun 2026
MR QuarterJun 2026
Employees—
CountryAU
SectorHealthcare
IndustryBiotechnology
ISINAU0000418782
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.14
EV/Revenue—
P/S—
P/B4.64
EPS (TTM)-0.04
EPS (Forward)—
52W Range
—
52W High—
52W Low—
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE-115.76%
ROA-97.79%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.31M USD
CapEx (TTM)—
FCF Margin—
FCF Yield—
Net Debt-3.10M USD
Net Debt/EBITDA0.65
Balance Sheet
Debt/Equity0.00
Current Ratio4.85
Quick Ratio4.47
Book Value/Sh0.03 AUD
Cash/Share0.02 AUD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 AUD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.202.00M
Float62.85M
Insiders60.13%
Institutions16.62%
Technical
SMA 500.1799 AUD
SMA 2000.2025 AUD
Beta—
S&P 52W Chg16.44%
Avg Vol (30d)—
Avg Vol (10d)282.22K
Technical Indicators
RSI (14)—
MACD—
MACD Signal—
MACD Hist.—
BB Upper—
BB Middle—
BB Lower—
BB Width—
ATR (14)—
Vol Ratio (20d)—